PaxMedica (PXMD) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock PXMD vs. CMRA, SYRS, EFTR, CLVR, ATNFW, LBPSW, AIMDW, ALVOW, ARAV, and ACABWShould you be buying PaxMedica stock or one of its competitors? The main competitors of PaxMedica include Comera Life Sciences (CMRA), Syros Pharmaceuticals (SYRS), eFFECTOR Therapeutics (EFTR), Clever Leaves (CLVR), 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Ainos (AIMDW), Alvotech (ALVOW), ARAVIVE (ARAV), and Atlantic Coastal Acquisition Corp. II (ACABW). These companies are all part of the "pharmaceutical products" industry. PaxMedica vs. Its Competitors Comera Life Sciences Syros Pharmaceuticals eFFECTOR Therapeutics Clever Leaves 180 Life Sciences 4D pharma Ainos Alvotech ARAVIVE Atlantic Coastal Acquisition Corp. II PaxMedica (NASDAQ:PXMD) and Comera Life Sciences (NASDAQ:CMRA) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, valuation, risk, earnings, media sentiment, institutional ownership and dividends. Is PXMD or CMRA more profitable? Comera Life Sciences' return on equity of 0.00% beat PaxMedica's return on equity.Company Net Margins Return on Equity Return on Assets PaxMedicaN/A -3,167.89% -560.35% Comera Life Sciences N/A N/A N/A Does the media favor PXMD or CMRA? In the previous week, PaxMedica's average media sentiment score of 0.00 equaled Comera Life Sciences'average media sentiment score. Company Overall Sentiment PaxMedica Neutral Comera Life Sciences Neutral Do institutionals & insiders have more ownership in PXMD or CMRA? 4.9% of PaxMedica shares are held by institutional investors. 1.0% of PaxMedica shares are held by company insiders. Comparatively, 8.9% of Comera Life Sciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has more volatility and risk, PXMD or CMRA? PaxMedica has a beta of -0.99, meaning that its stock price is 199% less volatile than the S&P 500. Comparatively, Comera Life Sciences has a beta of 1.18, meaning that its stock price is 18% more volatile than the S&P 500. Which has preferable earnings and valuation, PXMD or CMRA? Comera Life Sciences has higher revenue and earnings than PaxMedica. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPaxMedicaN/AN/A-$18.29MN/AN/AComera Life Sciences$1.00M0.00-$18MN/AN/A SummaryComera Life Sciences beats PaxMedica on 6 of the 7 factors compared between the two stocks. Get PaxMedica News Delivered to You Automatically Sign up to receive the latest news and ratings for PXMD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PXMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PXMD vs. The Competition Export to ExcelMetricPaxMedicaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2K$985.07M$6.07B$10.52BDividend YieldN/A4.84%5.68%4.68%P/E RatioN/A1.2577.4026.67Price / SalesN/A126.13518.66204.76Price / CashN/A17.6437.8961.26Price / BookN/A6.8012.556.55Net Income-$18.29M-$6.11M$3.30B$277.34M PaxMedica Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PXMDPaxMedicaN/AN/AN/AN/A$2KN/A0.002CMRAComera Life SciencesN/A$0.00-50.0%N/AN/A$3K$1.00M0.002Gap DownSYRSSyros Pharmaceuticals3.8354 of 5 stars$0.00-98.1%$1.00+999,900.0%-100.0%$3K$386K0.00120Gap DownEFTReFFECTOR Therapeutics0.0619 of 5 stars$0.00+150.0%N/A-99.3%$2KN/A0.0010Gap UpCLVRClever LeavesN/A$0.00flatN/AN/A$1K$17.42M0.00560ATNFW180 Life SciencesN/A$0.09+17.0%N/A+766.3%$0.00N/A0.007LBPSW4D pharmaN/AN/AN/AN/A$0.00$522K0.00N/AAIMDWAinosN/A$0.16-0.4%N/A+282.3%$0.00$110.87K0.0040Gap UpALVOWAlvotechN/A$1.49+36.7%N/A-52.5%$0.00$560.10M0.004Gap DownHigh Trading VolumeARAVARAVIVEN/A$0.04flatN/AN/A$0.00$9.14M0.0020High Trading VolumeACABWAtlantic Coastal Acquisition Corp. IIN/A$0.05flatN/AN/A$0.00N/A0.0015 Related Companies and Tools Related Companies CMRA Alternatives SYRS Alternatives EFTR Alternatives CLVR Alternatives ATNFW Alternatives LBPSW Alternatives AIMDW Alternatives ALVOW Alternatives ARAV Alternatives ACABW Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PXMD) was last updated on 10/3/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredShots officially fired…Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the righ...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PaxMedica, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PaxMedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
